Asthma in clinical practice : from inflammatory phenotypes to personalized treatment
Asthma is a chronic inflammatory disease of the airways. Classification of asthma in different phenotypes has therapeutic implications and may lead to personalized medicine. Induced sputum is the gold standard for asthma phenotyping but is complex, time-consuming and not widely available. The combination of different biomarkers such as exhaled nitric oxide, blood eosinophils and total serum IgE levels allows the prediction of inflammatory phenotype in 58% of asthmatic patients when sputum is not available. We recently demonstrated the interest of measuring volatile organic compounds in exhaled breath to phenotype asthma. These compounds could play an important role in the future to predict the response to expensive biologicals available in severe asthma to reduce exacerbations and the use of systemic corticosteroids.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:77 |
|---|---|
| Enthalten in: |
Revue medicale de Liege - 77(2022), 5-6 vom: 25. Mai, Seite 289-294 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
L’asthme bronchique en pratique clinique : des phénotypes inflammatoires au traitement personnalisé |
|---|
| Beteiligte Personen: |
Schleich, F [VerfasserIn] |
|---|
| Themen: |
Biologicals |
|---|
| Anmerkungen: |
Date Completed 08.06.2022 Date Revised 08.06.2022 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM341791458 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM341791458 | ||
| 003 | DE-627 | ||
| 005 | 20231226012603.0 | ||
| 007 | tu | ||
| 008 | 231226s2022 xx ||||| 00| ||fre c | ||
| 028 | 5 | 2 | |a pubmed24n1139.xml |
| 035 | |a (DE-627)NLM341791458 | ||
| 035 | |a (NLM)35657185 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Schleich, F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Asthma in clinical practice |b from inflammatory phenotypes to personalized treatment |
| 246 | 3 | 3 | |a L’asthme bronchique en pratique clinique : des phénotypes inflammatoires au traitement personnalisé |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 08.06.2022 | ||
| 500 | |a Date Revised 08.06.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Asthma is a chronic inflammatory disease of the airways. Classification of asthma in different phenotypes has therapeutic implications and may lead to personalized medicine. Induced sputum is the gold standard for asthma phenotyping but is complex, time-consuming and not widely available. The combination of different biomarkers such as exhaled nitric oxide, blood eosinophils and total serum IgE levels allows the prediction of inflammatory phenotype in 58% of asthmatic patients when sputum is not available. We recently demonstrated the interest of measuring volatile organic compounds in exhaled breath to phenotype asthma. These compounds could play an important role in the future to predict the response to expensive biologicals available in severe asthma to reduce exacerbations and the use of systemic corticosteroids | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Biologicals | |
| 650 | 4 | |a Eosinophils | |
| 650 | 4 | |a Inflammation | |
| 650 | 4 | |a Phenotype | |
| 650 | 4 | |a Bronchial asthma | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 700 | 1 | |a Graff, S |e verfasserin |4 aut | |
| 700 | 1 | |a Bougard, N |e verfasserin |4 aut | |
| 700 | 1 | |a Frix, A-N |e verfasserin |4 aut | |
| 700 | 1 | |a Peerboom, S |e verfasserin |4 aut | |
| 700 | 1 | |a Demarche, S |e verfasserin |4 aut | |
| 700 | 1 | |a Guissard, F |e verfasserin |4 aut | |
| 700 | 1 | |a Paulus, V |e verfasserin |4 aut | |
| 700 | 1 | |a Henket, M |e verfasserin |4 aut | |
| 700 | 1 | |a Calmès, D |e verfasserin |4 aut | |
| 700 | 1 | |a Moermans, C |e verfasserin |4 aut | |
| 700 | 1 | |a Louis, R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revue medicale de Liege |d 1947 |g 77(2022), 5-6 vom: 25. Mai, Seite 289-294 |w (DE-627)NLM000044490 |x 0370-629X |7 nnns |
| 773 | 1 | 8 | |g volume:77 |g year:2022 |g number:5-6 |g day:25 |g month:05 |g pages:289-294 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 77 |j 2022 |e 5-6 |b 25 |c 05 |h 289-294 | ||